vs
Apple Hospitality REIT, Inc.（APLE）与Axsome Therapeutics, Inc.（AXSM）财务数据对比。点击上方公司名可切换其他公司
Apple Hospitality REIT, Inc.的季度营收约是Axsome Therapeutics, Inc.的1.7倍（$326.4M vs $196.0M），Apple Hospitality REIT, Inc.净利率更高（9.1% vs -14.6%，领先23.6%），Axsome Therapeutics, Inc.同比增速更快（65.0% vs -2.0%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（61.7% vs -8.5%）
莱曼 hospitality properties是一家深耕酒店、度假村、娱乐及媒体领域的企业，得名于旗下核心资产——位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾作为爱德华·盖洛德旗下俄克拉荷马出版公司子公司的时期，1983年收购WSM公司后，拿下大奥普里等知名IP，奠定了如今的业务发展基础。
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
APLE vs AXSM — 直观对比
营收规模更大
APLE
是对方的1.7倍
$196.0M
营收增速更快
AXSM
高出67.0%
-2.0%
净利率更高
APLE
高出23.6%
-14.6%
两年增速更快
AXSM
近两年复合增速
-8.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $326.4M | $196.0M |
| 净利润 | $29.6M | $-28.6M |
| 毛利率 | — | — |
| 营业利润率 | 15.2% | -13.8% |
| 净利率 | 9.1% | -14.6% |
| 营收同比 | -2.0% | 65.0% |
| 净利润同比 | 82.5% | 61.9% |
| 每股收益（稀释后） | $0.13 | $-0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLEAXSM
| Q1 26 | $326.4M | — | ||
| Q4 25 | $326.4M | $196.0M | ||
| Q3 25 | $373.9M | $171.0M | ||
| Q2 25 | $384.4M | $150.0M | ||
| Q1 25 | $327.7M | $121.5M | ||
| Q4 24 | $333.0M | $118.8M | ||
| Q3 24 | $378.8M | $104.8M | ||
| Q2 24 | $390.1M | $87.2M |
净利润APLEAXSM
| Q1 26 | $29.6M | — | ||
| Q4 25 | $29.6M | $-28.6M | ||
| Q3 25 | $50.9M | $-47.2M | ||
| Q2 25 | $63.6M | $-48.0M | ||
| Q1 25 | $31.2M | $-59.4M | ||
| Q4 24 | $29.8M | $-74.9M | ||
| Q3 24 | $56.3M | $-64.6M | ||
| Q2 24 | $73.9M | $-79.3M |
毛利率APLEAXSM
| Q1 26 | — | — | ||
| Q4 25 | 37.2% | — | ||
| Q3 25 | 40.6% | — | ||
| Q2 25 | 42.6% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 41.9% | — | ||
| Q2 24 | 44.6% | — |
营业利润率APLEAXSM
| Q1 26 | 15.2% | — | ||
| Q4 25 | 15.2% | -13.8% | ||
| Q3 25 | 19.4% | -27.0% | ||
| Q2 25 | 22.1% | -24.5% | ||
| Q1 25 | 15.5% | -46.9% | ||
| Q4 24 | 15.0% | -61.1% | ||
| Q3 24 | 20.5% | -59.8% | ||
| Q2 24 | 24.0% | -89.5% |
净利率APLEAXSM
| Q1 26 | 9.1% | — | ||
| Q4 25 | 9.1% | -14.6% | ||
| Q3 25 | 13.6% | -27.6% | ||
| Q2 25 | 16.6% | -32.0% | ||
| Q1 25 | 9.5% | -48.9% | ||
| Q4 24 | 9.0% | -63.1% | ||
| Q3 24 | 14.9% | -61.7% | ||
| Q2 24 | 19.0% | -91.0% |
每股收益（稀释后）APLEAXSM
| Q1 26 | $0.13 | — | ||
| Q4 25 | $0.13 | $-0.55 | ||
| Q3 25 | $0.21 | $-0.94 | ||
| Q2 25 | $0.27 | $-0.97 | ||
| Q1 25 | $0.13 | $-1.22 | ||
| Q4 24 | $0.13 | $-1.54 | ||
| Q3 24 | $0.23 | $-1.34 | ||
| Q2 24 | $0.31 | $-1.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | $322.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.1B | $88.3M |
| 总资产 | $4.9B | $689.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLEAXSM
| Q1 26 | $8.5M | — | ||
| Q4 25 | $8.5M | $322.9M | ||
| Q3 25 | $50.3M | $325.3M | ||
| Q2 25 | $7.9M | $303.0M | ||
| Q1 25 | $14.9M | $300.9M | ||
| Q4 24 | $10.3M | $315.4M | ||
| Q3 24 | $6.1M | $327.3M | ||
| Q2 24 | $7.2M | $315.7M |
总债务APLEAXSM
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — |
股东权益APLEAXSM
| Q1 26 | $3.1B | — | ||
| Q4 25 | $3.1B | $88.3M | ||
| Q3 25 | $3.2B | $73.7M | ||
| Q2 25 | $3.2B | $73.1M | ||
| Q1 25 | $3.2B | $53.2M | ||
| Q4 24 | $3.3B | $57.0M | ||
| Q3 24 | $3.3B | $92.9M | ||
| Q2 24 | $3.3B | $102.9M |
总资产APLEAXSM
| Q1 26 | $4.9B | — | ||
| Q4 25 | $4.9B | $689.8M | ||
| Q3 25 | $4.9B | $669.3M | ||
| Q2 25 | $4.9B | $639.8M | ||
| Q1 25 | $4.9B | $596.7M | ||
| Q4 24 | $5.0B | $568.5M | ||
| Q3 24 | $5.0B | $561.5M | ||
| Q2 24 | $5.1B | $548.2M |
负债/权益比APLEAXSM
| Q1 26 | — | — | ||
| Q4 25 | 0.49× | — | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.46× | — | ||
| Q2 24 | 0.46× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-18.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-18.7M |
| 自由现金流率自由现金流/营收 | — | -9.6% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-93.9M |
8季度趋势，按日历期对齐
经营现金流APLEAXSM
| Q1 26 | — | — | ||
| Q4 25 | $370.2M | $-18.7M | ||
| Q3 25 | $126.4M | $1.0M | ||
| Q2 25 | $108.8M | $-32.4M | ||
| Q1 25 | $49.1M | $-43.4M | ||
| Q4 24 | $405.4M | $-26.2M | ||
| Q3 24 | $128.2M | $-18.6M | ||
| Q2 24 | $127.3M | $-30.1M |
自由现金流APLEAXSM
| Q1 26 | — | — | ||
| Q4 25 | $282.0M | $-18.7M | ||
| Q3 25 | $109.0M | $988.0K | ||
| Q2 25 | $96.2M | $-32.4M | ||
| Q1 25 | $29.5M | $-43.7M | ||
| Q4 24 | $327.1M | $-26.2M | ||
| Q3 24 | $113.1M | $-18.7M | ||
| Q2 24 | $115.0M | $-30.2M |
自由现金流率APLEAXSM
| Q1 26 | — | — | ||
| Q4 25 | 86.4% | -9.6% | ||
| Q3 25 | 29.2% | 0.6% | ||
| Q2 25 | 25.0% | -21.6% | ||
| Q1 25 | 9.0% | -36.0% | ||
| Q4 24 | 98.2% | -22.1% | ||
| Q3 24 | 29.9% | -17.9% | ||
| Q2 24 | 29.5% | -34.6% |
资本支出强度APLEAXSM
| Q1 26 | — | — | ||
| Q4 25 | 27.0% | 0.0% | ||
| Q3 25 | 4.7% | 0.0% | ||
| Q2 25 | 3.3% | 0.0% | ||
| Q1 25 | 6.0% | 0.3% | ||
| Q4 24 | 23.5% | 0.0% | ||
| Q3 24 | 4.0% | 0.1% | ||
| Q2 24 | 3.2% | 0.1% |
现金转化率APLEAXSM
| Q1 26 | — | — | ||
| Q4 25 | 12.50× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 1.71× | — | ||
| Q1 25 | 1.57× | — | ||
| Q4 24 | 13.59× | — | ||
| Q3 24 | 2.28× | — | ||
| Q2 24 | 1.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLE
| Comparable Hotels Total Revenue | $319.2M | 98% |
| Other | $7.1M | 2% |
| RevPAR (Comparable Hotels) | $106.9K | 0% |
AXSM
暂无分部数据
